retatrutide and mots c Reta + MOTS-C Only Mots-C 10mg — Retatrulean
Description
It's a tailored approach
The primary efficacy parameter was mean percent change in BMI from baseline after 52 weeks on a therapeutic regimen of setmelanotide compared to placebo
doi:10.1002/epi4.13091 113
Researchers should review all available product information before ordering
1998 Aug;43(8):665-70
Additionally, one of the study authors reports receiving an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk and receiving consulting fees from Currax Pharmaceuticals, LLC
